Cargando…

The Role of the Lung’s Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing interstitial lung disease that commonly affects older adults and is associated with the histopathological and/or radiological patterns of usual interstitial pneumonia (UIP). Despite significant advances in our understanding of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spagnolo, Paolo, Molyneaux, Philip L., Bernardinello, Nicol, Cocconcelli, Elisabetta, Biondini, Davide, Fracasso, Federico, Tiné, Mariaenrica, Saetta, Marina, Maher, Toby M., Balestro, Elisabetta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6888416/ https://www.ncbi.nlm.nih.gov/pubmed/31717661 http://dx.doi.org/10.3390/ijms20225618

Ejemplares similares

Idiopathic Pulmonary Fibrosis and Lung Transplantation: When it is Feasible
por: Balestro, Elisabetta, et al.
Publicado: (2019)

CA 19-9 serum levels in patients with end-stage idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILDs): Correlation with functional decline
por: Balestro, Elisabetta, et al.
Publicado: (2020)

Pleural clinic: where thoracic ultrasound meets respiratory medicine
por: Tinè, Mariaenrica, et al.
Publicado: (2023)

Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism
por: Cocconcelli, Elisabetta, et al.
Publicado: (2022)

Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment
por: Biondini, Davide, et al.
Publicado: (2021)

Molecular Mechanism in the Development of Pulmonary Fibrosis in Patients with Sarcoidosis
por: Cocconcelli, Elisabetta, et al.
Publicado: (2023)

High-Resolution CT Change over Time in Patients with Idiopathic Pulmonary Fibrosis on Antifibrotic Treatment
por: Balestro, Elisabetta, et al.
Publicado: (2019)

Chronic Bronchitis Affects Outcomes in Smokers without Chronic Obstructive Pulmonary Disease (COPD)
por: Casara, Alvise, et al.
Publicado: (2022)

Characteristics and Prognostic Factors of Pulmonary Fibrosis After COVID-19 Pneumonia
por: Cocconcelli, Elisabetta, et al.
Publicado: (2022)

Thoracic Involvement in Systemic Autoimmune Rheumatic Diseases: Pathogenesis and Management
por: De Zorzi, Elena, et al.
Publicado: (2022)

Heart Failure is Highly Prevalent and Difficult to Diagnose in Severe Exacerbations of COPD Presenting to the Emergency Department
por: Tinè, Mariaenrica, et al.
Publicado: (2020)

Pulmonary fibrosis secondary to COVID-19: a call to arms?
por: Spagnolo, Paolo, et al.
Publicado: (2020)

Clinical Features and Chest Imaging as Predictors of Intensity of Care in Patients with COVID-19
por: Cocconcelli, Elisabetta, et al.
Publicado: (2020)

Macrophages-derived Factor XIII links coagulation to inflammation in COPD
por: Bazzan, Erica, et al.
Publicado: (2023)

Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis
por: Biondini, Davide, et al.
Publicado: (2018)

Pulmonary Sarcoidosis: Diagnosis and Differential Diagnosis
por: Bernardinello, Nicol, et al.
Publicado: (2021)

The Role of Bronchoscopy in the Diagnosis and Management of Patients with SARS-Cov-2 Infection
por: Biondini, Davide, et al.
Publicado: (2021)

High-Resolution Computed Tomography (HRCT) Reflects Disease Progression in Patients with Idiopathic Pulmonary Fibrosis (IPF): Relationship with Lung Pathology
por: Cocconcelli, Elisabetta, et al.
Publicado: (2019)

Critical Review of the Evolution of Extracellular Vesicles’ Knowledge: From 1946 to Today
por: Bazzan, Erica, et al.
Publicado: (2021)

Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis
por: Balestro, Elisabetta, et al.
Publicado: (2016)

Disease Severity and Prognosis of SARS-CoV-2 Infection in Hospitalized Patients Is Not Associated With Viral Load in Nasopharyngeal Swab
por: Cocconcelli, Elisabetta, et al.
Publicado: (2021)

Predictors of pulmonary sequelae after COVID-19 pneumonia: A 12-month follow-up study
por: Bernardinello, Nicol, et al.
Publicado: (2023)

Do Circulating Extracellular Vesicles Strictly Reflect Bronchoalveolar Lavage Extracellular Vesicles in COPD?
por: Tinè, Mariaenrica, et al.
Publicado: (2023)

Exome Sequencing Reveals Immune Genes as Susceptibility Modifiers in Individuals with α(1)-Antitrypsin Deficiency
por: Rigobello, Chiara, et al.
Publicado: (2019)

The Emerging Role of Extracellular Vesicles Detected in Different Biological Fluids in COPD
por: Neri, Tommaso, et al.
Publicado: (2022)

Early Airway Pathological Changes in Children: New Insights into the Natural History of Wheezing
por: Bonato, Matteo, et al.
Publicado: (2019)

Brief communication: Chest radiography score in young COVID-19 patients: Does one size fit all?
por: Castelli, Gioele, et al.
Publicado: (2022)

Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity
por: Bazzan, Erica, et al.
Publicado: (2017)

Reassessing the Role of Eosinophils as a Biomarker in Chronic Obstructive Pulmonary Disease
por: Tinè, Mariaenrica, et al.
Publicado: (2019)

Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
por: Molyneaux, Philip L., et al.
Publicado: (2017)

Clinical Presentations, Pathogenesis, and Therapy of Sarcoidosis: State of the Art
por: Polverino, Francesca, et al.
Publicado: (2020)

Reducing lung function decline in patients with idiopathic pulmonary fibrosis: potential of nintedanib
por: Woodcock, Hannah V, et al.
Publicado: (2013)

Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges
por: Spagnolo, Paolo, et al.
Publicado: (2012)

Cognitive and Psychological Sequelae of COVID-19: Age Differences in Facing the Pandemic
por: Devita, Maria, et al.
Publicado: (2021)

The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2021)

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2019)

Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings
por: Renzoni, Elisabetta, et al.
Publicado: (2014)

Risk and Protective Factors of Psychological Distress in Patients Who Recovered From COVID-19: The Role of Cognitive Reserve
por: Devita, Maria, et al.
Publicado: (2022)

The Challenging Road of Moving from Association to Causation for Microbiome Research in Idiopathic Pulmonary Fibrosis
por: Segal, Leopoldo N., et al.
Publicado: (2019)

Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases
por: Amati, Francesco, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7gg9690o5s9rq8d5e2nbkjic36